Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second-Line Uterotonics in Postpartum Hemorrhage
NCT03584854Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylergometrine, carboprost in postpartum hemorrhage (PPH), uterine atony, sponsored by Brigham and Women's Hospital. Started Mar 2019; status: completed.
02
Drugs
methylergometrinecarboprost
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT03584854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03584854.